Welcome to
Chemical Collective

Are you 18 or older?

Please confirm that your are 18 years of age or older.

You are not allowed to access the page.

I am 18+

EXIT

SALE NOW ON!

Beyond THC: How Cannabis Terpenes Shape Your High

By David Blackbourn

By David Blackbourn

Disclaimer: The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of Chemical Collective or any associated parties.

Even though it is the foundation of a multi-billion-dollar legal, global industry, and a likely far more lucrative black market, scientific knowledge and research on cannabis is still far behind that of other high-value crops. This is mainly a result of legal restrictions that have stopped the majority of researchers from studying cannabis, its constituents, and their effects on humans.

Cannabis has been described as a “biopharmacy”, which contains over 100 compounds, including tetrahydrocannabinol (THC), which causes a “high,” and cannabidiol (CBD), which does not. The other compounds consist of myriad other, as yet barely studied, minor cannabinoids, as well as tiny compounds called terpenes. Terpenes are not unique to cannabis; they are the basic constituents of all essential oils. You find them throughout nature, from pine trees to orange peel. Terpenes are widely accepted as responsible for the smells and tastes of a huge number of substances. That familiar, skunky, signature scent of cannabis? That’s terpenes.

They are synthesised in the trichomes, the tiny, glandular hairs on the surface of cannabis plants, which have been described as “a cellular metabolite factory”. The trichomes are also responsible for producing THC and CBD. Terpenes have multiple natural purposes. They help the plant survive, deter hungry predators, and lure potential pollinators. But do they have more of an effect on cannabis’ powerful therapeutic and consciousness-altering effects than previously thought?

Indica vs Sativa

Cannabis indica and Cannabis sativa are two types, or strains, of the cannabis plant. As plants, the two strains look different. Indica is a shorter, stockier plant with broader leaves and a thick, woody stalk. Sativa is taller, slimmer, with thin leaves, and they grow more rapidly, but take longer to mature. There are also many types of hybrid plants with properties of both strains.

More than 1,000 strains of cannabis have been bred during the past several decades. It is critical that patients are aware of the different effects available, especially when considering cannabis’ medical effects. Some varieties of cannabis are most appropriate for particular diseases and ailments, but not others. Choosing the right strain is paramount. However, sativa and indica have more differences than simply their physical characteristics. Each strain of cannabis has a different ratio of CBD to THC, and this is known to alter how they affect your body. But plant strain is only one of the things that impact this.

Honestly, if you’re still using the widely understood “indica/sativa” labels to predict the effects of a particular strain of cannabis, you are behind the curve. The hybridisation of strains alone, in the vast majority of circumstances, means the indica/sativa label, even at this low level, is not an adequate means of differentiating strains and their effects. Modern research is beginning to reveal that a strain’s terpene profile is a far more effective means of determining strain effects. With legalisation spreading, especially in the U.S, ever savvier patients and consumers are demanding strains with specific terpene combinations. Post-2012 legalisation triggered a 435% spike in terpene testing in Colorado, for example. Indica/sativa, at this point, seems to be outdated marketing, with little relevance outside of their cultural ubiquity and presence in the vernacular.

The first, albeit wholly unscientific, terpene selection protocols emerged in much the same way as the early selective breeding of staples like corn, or even animals like cows. Ancient Persians burned frankincense (rich in the well-known terpene, pinene) in temples for “mental clarity”, unknowingly leveraging terpenes’ psychoactivity. 12th-century Arabian hashish makers prioritised fragrant, sticky plants, again seeking out terpenes without knowing it. The 1970s “landrace rush” saw breeders like Neville Schoenmaker chase Thai sativas not for their THC or CBD content, but their powerful limonene haze, birthing terpene-rich legends like Haze Bros’ “Original H”.

Our understanding of differences in strains and terpenes’ seemingly wide-ranging effects in cannabis is rudimentary at best. As a result of this, there is concern about a lack of consistency with regard to the terpene and cannabinoid composition of different types of cannabis. This is particularly pertinent when claims of particular medicinal properties or health benefits attributed to cannabis and its constituents are concerned. This would benefit from a thorough investigation.

Biosynthesis and Ecology

The building blocks of our current understanding of terpenes are isoprene units, tiny 5-carbon chains which link together like Lego to form different terpene molecules. The particular class of terpenes is determined by how many of these isoprene units link up:

Monoterpenes (2 units = 10 carbon atoms): Zesty, lemony, citrus.
Sesquiterpenes (3 units = 15 carbon atoms): Earthy, peppery.
Diterpenes (4 units = 20 carbon atoms): Bitter, coffee.
Triterpenes (6 units = 30 carbon atoms): Fresh grass, herbal.

Terpenes are synthesised via two main routes: the mevalonate (MVA) pathway and the methylerythritol phosphate (MEP) pathway. The MEP pathway is key to a plant’s ability to photosynthesise and is responsible for the production of monoterpenes and diterpenes. The MVA pathway is involved in the synthesis of sesquiterpenes and triterpenes. Both pathways contribute to the precursor molecules, IPP and DMAPP. These precursors are catalysed by enzymes called terpene synthases that reshape these precursors into the final terpenes.

But why does cannabis invest so much energy in these tiny, aromatic molecules? Survival. Terpenes have multiple uses:

Bug repellent: Limonene and pinene attack pests like natural pesticides.
Attracting pollinators: Floral linalool or sweet terpinolene attracts insects like bees.
Stress protection: Terpenes help stabilise cell membranes, which can help to protect the plant from potentially harmful UV rays.

This knowledge has already been employed by enterprising growers and breeders. Particular stressors can be manipulated artificially. For example, controlled drought or UV light can boost the production of particular terpenes. Simply put, understanding the biosynthesis of cannabis lets us engineer richer aromas and stronger effects in a far more controlled manner than simple selective breeding practices. New technologies are allowing commercial growers to take this to a whole new level, utilising gene editing techniques like CRISPR.

The CRISPR technique (Clustered Regularly Interspaced Short Palindromic Repeats) was developed in 2012 by the French researcher Emmanuelle Charpentier and the American researcher Jennifer A. Doudna. It has brought about a revolution in genetic engineering and could have such a wide-ranging impact that both received the Nobel Prize in Chemistry in 2020.

CRISPR is a particularly precise gene editing technique, which allows for the severing of the DNA sequences which form genes. Genes dictate traits. For example, in cannabis, this may be as simple as leaf colour, or as complex as the rate of THC/CBD synthesis. This incredibly accurate, specific method of breeding new variations of the plant on a gene-by-gene basis will allow future growers to hone in on specific terpenes to facilitate their desired effects on the individual consumer.

Key Terpenes and Effects

Let’s completely place both THC and CBD percentages/ratios to the side and focus solely on the perceived effects of each individual terpene.

Myrcene – Relaxation. With its earthy, musky aroma, it is the most common terpene in modern cannabis strains. High-myrcene strains like Granddaddy Purple deliver that classic couch-lock effect traditionally associated with “indica” strains. Scientific investigation suggests it perhaps boosts THC’s absorption too, potentially increasing the pain or insomnia-relieving properties of certain strains.

Limonene – Euphoric. The zingy, citrus scent of strains like Lemon Skunk is perceived to promote mood elevation and stress relief. The science suggests possible anti-anxiety and even anti-tumour potential.

Pinene – Stimulation. The pine-like aroma of classics like Jack Herer is thought to cut through brain fog associated with cannabis use. This may be due to pinene’s possible ability to counteract THC-induced short-term memory loss. It can also act as a bronchodilator, widening airways, ideal for asthmatics.

Linalool – Relaxation. The familiar scent of lavender. Floral and delicate, it is the backbone of many relaxing strains like LA Confidential, often in combination with Myrcene. Research also links it to reduced anxiety and protection from seizures, making it a potentially powerful tool for medicinal cannabis users.

Caryophyllene – Anti-inflammatory. Found in spicy strains like Girl Scout Cookies, it actually binds directly to CB2 receptors (like cannabinoids themselves). This can provide powerful, targeted inflammation relief.

Terpinolene – Uplifting/Sedating. Floral, herbal, see: Ghost Train Haze.

The Entourage Effect

So, as our knowledge of terpenes’ effects grows, we can begin to think of cannabis strains as a whole, with the ratios of all elements working together to produce particular effects. While THC might be the main chemical responsible for the powerful head change, we know that THCA isolate is widely available and effective. Without terpenes and other cannabinoids, the experience is flat, dulled somehow. Cannabinoids and terpenes work better together. This is what is known as the entourage effect.

The entourage effect is the theory that all of the compounds in cannabis synergise to create effects greater than any single molecule could achieve alone.

When University of Arizona researchers tested terpenes like linalool and humulene alongside cannabinoids, they found that terpenes activated CB1 receptors similarly to THC, which amplified the perceived pain relief without any additional unwanted side effects.

A rigorous Johns Hopkins/University of Colorado study gave subjects pure THC or THC + limonene. The limonene group reported significantly less anxiety than THC alone. Limonene didn’t just add a citrusy flavour; it actively modulated THC’s psychoactivity to assist its positive effects in outweighing any potential negatives.

For medical users, this means that full-spectrum extracts (with terpenes intact) will often outperform isolated CBD or THC. For recreational consumers? It explains why pure THC distillate/isolate highs feel harsher than whole-flower experiences.

So, how do we begin to re-categorise cannabis strains so consumers are more accurately able to determine the effects they want from them?

Chemovars

Step one is to bury the indica/sativa, body high/cerebral buzz myth, as the science obviously refutes its effectiveness as a means of categorisation.

When researchers analysed 140 commercially labelled strains, they found zero consistent differences in terpene profiles between “indicas,” “sativas,” or hybrids. The chemistry of the “energising sativa” you purchased may well be near-identical to a so-called “indica” from the same exact source.

Enter chemovars, a classification system that actually works. Instead of vague growth traits, outlandish names, or THC/CBD percentage, chemovars categorise cannabis by its complete chemical fingerprint:

The dominant cannabinoids and ratios of minor cannabinoids.
The complete terpene analysis and their ratios.

For recreational consumers, this provides much more clarity. If we compare cannabis to wine for a moment. Consider how you choose something like wine. You wouldn’t call all reds “energising” or all whites “sedating.” You would check the chemistry. This obviously isn’t a complex, scientific task for the consumer themself. The acidity, terroir, etc. of the wine are clearly listed on the bottle and provide an accurate indication of the smell, taste, and effects of the product within. Similarly, Jack Herer, commonly listed solely as “sativa-dominant”, could be recategorised as a Type I chemovar (THC-dominant + limonene/pinene), which would indicate it will have a strong “stoned” effect, combined with potentially powerful euphoria/stimulation.

This revolution in specificity matters for medical patients, too. Targeting chronic pain? Look for a Type I chemovar with high caryophyllene for its additional anti-inflammatory qualities. It also allows growers to hone in on specific traits far more effectively, improving the speed and accuracy with which new strains can be developed.

Bottom line? Strain names are marketing poetry. Chemovars are scientific truth. As testing advances, expect your dispensary menu to shift from:

Sour Diesel – Sativa

To:

Sour Diesel – Fuel Chemovar, THC-dominant, 24%, High pinene

This will finally give you clarity and control over your experience.

David Blackbourn | Community Blogger at Chemical Collective

David is one of our community bloggers here at Chemical Collective. If you’re interested in joining our blogging team and getting paid to write about subjects you’re passionate about, please reach out to Sam via email at samwoolfe@gmail.com

share your toughts

Join the Conversation.

0 Comments

Inline Feedbacks

View all comments

9 minute read

In his book The Weird and the Eerie, cultural theorist Mark Fisher analyses the concept of the 'weird'. Sam Woolfe applies Fisher's analysis to psychedelic states.

09 Feb, 2026

Opinion | Psychedelics and Mark Fisher’s Theory of the Weird

Sam Woolfe

13 minute read

Un aperçu objectif du protoxyde d'azote, examinant sa normalisation croissante, ses effets puissants, son attrait, ses risques et son histoire.

07 Feb, 2026

Guides | Le gaz hilarant : Le protoxyde d’azote (N2O)

Nuit

13 minute read

Nuit compare les expériences de LSA issues de deux sources de semences, contextualisées par l'histoire et la science, dans le but de présenter une vision équilibrée des effets variables, des incertitudes, des risques et des enseignements de la LSA.

05 Feb, 2026

Personal Stories | Le LSA : la version naturelle du LSD ?

Nuit

12 minute read

Stroke, traumatic brain injury, and neurodegenerative diseases are leading, interconnected causes of global disability and economic burden with limited effective treatments. Sam Gandy highlights the potential of psychedelics as novel therapies to promote brain repair and recovery.

03 Feb, 2026

Science | Can Psychedelics Help Mend Broken and Ailing Brains?

Sam Gandy

11 minute read

The ancient, subterranean networks of fungi underpin life on Earth and are now emerging as a powerful foundation for future sustainable biotechnologies.

01 Feb, 2026

Science | Beyond the Trip: How Fungi Are Engineering Our Future

David Blackbourn

8 minute read

Dans la deuxième partie de ce guide sur l'influence du dosage sur les expériences psychédéliques, Eliacide examine les combinaisons de drogues et les expériences qui ne visent pas à dissoudre l'ego.

30 Jan, 2026

Guides | L’influence du dosage sur les expériences psychédéliques (Partie 2)

Eliacide

9 minute read

Eliacide explique que le dosage des médicaments est très subjectif et doit être choisi en fonction du niveau d'expérience personnel et du contexte souhaité, avertissant que les débutants doivent éviter les doses élevées et encourageant les individus à trouver leur propre « juste milieu » plutôt que de considérer tout conseil comme absolu.

28 Jan, 2026

Guides | L’influence du dosage sur les expériences psychédéliques (Partie 1)

Eliacide

9 minute read

Real-world data confirms the extremely low physical risk of psychedelics; the NHS and FDA intensify their scrutiny of clinical rollout; and we see expanding legal momentum in the US, as well as a shift towards shorter-acting compounds and even non-hallucinogenic, virtual alternatives.

26 Jan, 2026

All Articles | PSYCH NEWS – 26/01/2026

David Blackbourn

12 minute read

Nuit s'entretient avec Andrés Gómez, chercheur en conscience à l'Institut de recherche Qualia, qui fait le lien entre la science informatique, les récits expérientiels, les traditions contemplatives orientales et la recherche psychédélique.

25 Jan, 2026

Personal Stories | Mon échange avec le chercheur Andrés Gómez Emilson

Nuit

10 minute read

John Robertson offers a practical guide to understanding the causes of non-responses to psychedelics and what to do to move beyond them safely and effectively.

24 Jan, 2026

Guides | The ‘Nada’ Experience: What To Do When Psychedelics Don’t Work (Part 2)

John Robertson

7 minute read

Alfredo Squillaro argues that informed use, drug checking, and education are far more effective than stigma and repression in reducing the risks of psychoactive substance use.

22 Jan, 2026

Opinion | (Anti)prohibition, Psychonautics, and Designer Drugs

Alfredo Squillaro

11 minute read

Oli Genn-Bash reflects on the Western pursuit of an “authentic self,” using personal psychedelic experiences to question whether self-discovery is less about uncovering a fixed identity and more about cultivating a healthy relationship with the self that allows it to soften, open, and connect with others.

20 Jan, 2026

Self-Development | Discovering the Authentic Self Through Psychedelics

Oli Genn-Bash

9 minute read

Free parties can be understood as modern expressions of ancient ritual practices – akin to the Dionysian Mysteries – where music, dance, and psychoactive substances induce ecstatic states of consciousness.

18 Jan, 2026

Opinion | Dionysian Cults and Free Parties

Alfredo Squillaro

13 minute read

Nuit décrit son expérience du 2C-P comme un psychédélique puissant, à action lente et prolongée, appartenant à la famille des 2C-x – davantage comparable à une longue et exigeante randonnée qu'à un simple voyage.

16 Jan, 2026

Personal Stories | 2C-P : La charrette psychédélique

Nuit

11 minute read

Can psychedelics genuinely challenge and undermine the military-industrial complex by transforming consciousness, or do they risk being co-opted to merely help individuals psychologically adapt to an inherently violent and unjust system?

14 Jan, 2026

Opinion | Decentralised Minds: Can Psychedelics Undermine the Military Industrial Complex?

Oli Genn-Bash

11 minute read

Oli Genn-Bash explores the growing popularity of functional mushrooms, blending personal experience, research, and traditional perspectives to argue for a more holistic, respectful understanding of fungi.

12 Jan, 2026

Opinion | A Holistic and Spiritual Approach to Functional Mushrooms

Oli Genn-Bash

11 minute read

Despite bold promises surrounding psychedelics, a significant share of patients fail to meaningfully improve, revealing that non-response is a central – and often overlooked – challenge in psychedelic therapy.

10 Jan, 2026

Science | Let’s Talk About Non-Responders in Psychedelic Therapy

Ed Prideaux

8 minute read

Psychedelic use is commonly divided into spiritual, therapeutic, and recreational categories whose meanings are unclear and unevenly valued, with recreational use often stigmatised despite having aspects that deserve reconsideration.

08 Jan, 2026

Opinion | In Defence of Recreational Psychedelic Use

Annabelle Abraham

15 minute read

The Immortality Key builds a sweeping psychedelic-religion narrative on evidence that its own primary scientific authority later rejected as methodologically flawed, undermining the book’s credibility despite its popular success.

06 Jan, 2026

History | Psychedelic Bullshit? An Evaluation of The Immortality Key

Ed Prideaux

10 minute read

Over the past year, the psychedelic field has seen unprecedented scientific and regulatory advances collide with bureaucratic barriers and venture capital pressures, revealing both rapid progress toward medical integration and the fragility – and cultural tension – of an emerging industry at a pivotal moment.

04 Jan, 2026

News & Updates | PSYCH NEWS 2025 – THE YEAR IN REVIEW

David Blackbourn

8 minute read

Martha Allitt unpacks the history of MK-ULTRA, a secret CIA program that conducted unethical experiments with LSD, hypnosis, and other techniques in an attempt to develop methods of mind control and psychological manipulation during the Cold War.

04 Jan, 2026

History | MK-ULTRA: A Macabre History of LSD and Mind Control

Martha Allitt

16 minute read

Ed Prideaux examines Elon Musk’s alleged drug use and public behaviour in the context of his immense political and technological influence.

02 Jan, 2026

Opinion | High on Power: How Much Does Ketamine Explain Elon Musk’s Erratic Behaviour?

Ed Prideaux

10 minute read

Psychedelics can help us rethink the “hard problem” of consciousness by challenging the materialist view that the brain generates experience.

30 Dec, 2025

Philosophy | Psychedelics and the Hard Problem of Consciousness

David Blackbourn

12 minute read

Nuit décrit le 2C-C comme un membre subtil et apaisant de la famille 2C-X, qui évoque de doux souvenirs d'expériences sereines et introspectives.

28 Dec, 2025

Guides | 2C-C : la version Stone du 2C-B ?

Nuit

4 minute read

Theories suggest that N,N-dimethyltryptamine (DMT) is released in our brains when we die – but what do we really know about this potent psychedelic and its endogenous role in the human body?

22 Dec, 2025

Science | The Endogenous DMT Narrative: Separating Fact From Fiction

Stephanie Price

11 minute read

While psychedelics get most of the limelight in discussions about altered states of consciousness, such states can also be accessed through more accessible and potentially safer means, particularly sound baths.

20 Dec, 2025

Spirituality | Sound Baths and Altered States

Oli Genn-Bash

9 minute read

David Blackbourn explores the history and present-day use of psychoactive substances in the Middle East, including the religious, social, and political factors that have influenced this usage.

18 Dec, 2025

History | Contemporary Psychoactive Drug Use in the Middle East

David Blackbourn

8 minute read

Iboga, a West African shrub traditionally used in the Bwiti spiritual tradition, is now being used for microdosing in the West.

16 Dec, 2025

Personal Stories | Microdosing Iboga: Why People Are Taking Tiny Amounts of a Hallucinogenic Shrub

Martha Allitt

5 minute read

Clinical trials typically evaluate psychedelics through short-term before-and-after measures to assess treatment efficacy, but longer-term and lifelong effects are harder to quantify.

14 Dec, 2025

Self-Development | The Long-Term Effects of Psychedelics Are Sometimes Ambiguous

Annabelle Abraham

11 minute read

While psychedelic insights may be valuable, they can be difficult to interpret and require a broader psychological, spiritual, philosophical, or cultural framework to determine whether they reflect genuine truth or mere subjective experience.

12 Dec, 2025

Self-Development | Psychedelics and Epistemic Authority: How Can We Trust Psychedelic Insights?

Oli Genn-Bash

Our Products

Related Products

SALE! -35%

1V-LSD 150mcg Blotters From

(145)

1cP-LSD 100mcg Blotters From 18.00

(137)

Tryptamine Mix and Match Pack (4 x 0.1g) €65.00

(1)

SALE! -35%

1V-LSD 10mcg Micro Pellets From

(44)

SALE! -35%

1V-LSD 225mcg Art Design Blotters From

(62)

1S-LSD 150mcg Blotters From 29.00

(18)

1cP-LSD 150mcg Art Design Blotters From 25.00

(74)

SALE! -35%

1V-LSD 225mcg Pellets From

(26)

1cP-LSD 10mcg Micro Pellets From 15.00

(23)

1D-LSD 225mcg Pellets (1T-LSD) From 42.00

(13)

5-MeO-DMT Freebase From 23.95

(36)

1S-LSD 10mcg Micro Pellets €20.00

(3)

O-PCE HCL From 17.50

(25)

1cP-LSD 20mcg Micro Blotters From 18.00

(28)

1cP-LSD 150mcg Pellets From 25.00

(13)

see all products

Earn
Affiliates

Welcome to Chemical Collective.

Create an account to earn 200 welcome points.

create account

Already have an account? Sign in

Comment on an article

50

Check out our Community Blog and get involved with the conversation. You will be awarded 50 x ChemCoins for each comment up to a limit of 250 total ChemCoins.
Leave a product review

50

Have you purchased any of our products? Reviews and reports are so important to the community. Share your honest opinion, and we’ll reward you with 50 ChemCoins for each review!
Complete an order

X

Every time you complete an order with us, you’ll be awarded ChemCoins for each Euro spent.

Welcome to Chemical Collective.

Create an account to earn 200 welcome points.

create account

Already have an account? Sign in

Become an affiliate!

Earn commission every time someone makes a purchase through your link.

When you become an affiliate, you will be allocated a unique link to share with your friends, followers, subscribers, or Aunt Susan.

You can choose to payout the commission earned once per month, or save it up to receive on a rainy day! Commission earned is 5% of the total order value per referral.

Contact us to join the Chemical Collective family and become an affiliate.

Welcome toChemical Collective

Beyond THC: How Cannabis Terpenes Shape Your High

By David Blackbourn

in this article

By David Blackbourn

Indica vs Sativa

Biosynthesis and Ecology

Key Terpenes and Effects

The Entourage Effect

Chemovars

By David Blackbourn

share your toughts

Join the Conversation.

Related articles

Related Products

Reward program

Comment on an article

Leave a product review

Complete an order

Become an affiliate!

Welcome to
Chemical Collective